Sejong, South Korea

Sungeun Yoo

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Kainos Medicine Inc.. Active years: 2022-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sungeun Yoo. Retrieved from https://idiyas.com/inventor/sungeun-yoo-vn5x44vb

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 4.2

ph-index = 1


Company Filing History:


Years Active: 2022-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Sure, here is the article about inventor Sungeun Yoo:

Title: Unveiling the Innovations of Sungeun Yoo in Sejong, South Korea

Introduction:

Meet Sungeun Yoo, a talented inventor based in Sejong, South Korea, who has made significant contributions to the field of pharmaceuticals.

Latest Patents:

Sungeun Yoo holds 1 patent for a groundbreaking invention titled "Salt forms of organic compound" which discloses a salt compound of 4-(2-((4-bromophenyl)thio)acetamido)-1-phenethyl-1H-pyrazole-3-carboxylic acid. This patent also encompasses methods for synthesizing the salt compound and formulating it into dosage forms for clinical use.

Career Highlights:

Currently, Sungeun Yoo is associated with Kainos Medicine Inc., a leading pharmaceutical company known for its innovative research and development in healthcare solutions.

Collaborations:

Throughout his career, Sungeun Yoo has collaborated with esteemed colleagues such as Jae Moon Lee and Sunmi Shin. Their combined efforts have led to the successful exploration of new avenues in pharmaceutical research.

Conclusion:

In conclusion, Sungeun Yoo's dedication to innovation and his pioneering work in the pharmaceutical industry exemplify his commitment to advancing healthcare solutions. His patent stands as a testament to his ingenuity and drive for excellence in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…